IT-05 ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION

INTRODUCTION: Recurrent high grade glioma (rHGG) remains one of the most deadly cancers. Investigational agents Toca 511, a retroviral replicating vector, and Toca FC (extended-release 5-FC) are used in combination to target residual tumor at the time of resection. METHODS: This study (NCT01470794)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cloughesy, Timothy F., Kesari, Santosh, Kalkanis, Steven, Mikkelsen, Tom, Landolfi, Joseph, Elder, J. Bradley, Liau, Linda M., Chen, Clark C., Bloomfield, Stephen, Piccioni, David, Chiocca, E. Antonio, Foltz, Greg, Robbins, Joan M., Ostertag, Derek, Jolly, Doug J., Ibañez, Carlos, Pertschuk, Dan, Pan, Christine, Vogelbaum, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2014
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218255/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares